These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9868972)
1. Reduced adipocyte insulin sensitivity in Caucasian and Asian subjects with coronary heart disease. Frost GS; Keogh BE; Smith D; Leeds AR; Dornhorst A Diabet Med; 1998 Dec; 15(12):1003-9. PubMed ID: 9868972 [TBL] [Abstract][Full Text] [Related]
2. Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature myocardial infarction. Kooner JS; Baliga RR; Wilding J; Crook D; Packard CJ; Banks LM; Peart S; Aitman TJ; Scott J Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1021-6. PubMed ID: 9672061 [TBL] [Abstract][Full Text] [Related]
3. Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians. Genetic or environmental effect? Dhawan J; Bray CL; Warburton R; Ghambhir DS; Morris J Br Heart J; 1994 Nov; 72(5):413-21. PubMed ID: 7818957 [TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians. Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814 [TBL] [Abstract][Full Text] [Related]
5. Relation of plasma lipids to insulin resistance, nonesterified fatty acid levels, and body fat in men from three ethnic groups: relevance to variation in risk of diabetes and coronary disease. Zoratti R; Godsland IF; Chaturvedi N; Crook D; Crook D; Stevenson JC; McKeigue PM Metabolism; 2000 Feb; 49(2):245-52. PubMed ID: 10690953 [TBL] [Abstract][Full Text] [Related]
6. Ethnic differences in the responsiveness of adipocyte lipolytic activity to insulin. Buthelezi EP; van der Merwe MT; Lönnroth PN; Gray IP; Crowther NJ Obes Res; 2000 Mar; 8(2):171-8. PubMed ID: 10757203 [TBL] [Abstract][Full Text] [Related]
7. Ethnicity and risk factors for coronary heart disease in diabetes mellitus. Game FL; Jones AF Diabetes Obes Metab; 2000 Apr; 2(2):91-7. PubMed ID: 11220529 [TBL] [Abstract][Full Text] [Related]
8. Insulin sensitivity in non-diabetic relatives of patients with non-insulin-dependent diabetes from two ethnic groups. Gelding SV; Niththyananthan R; Chan SP; Skinner E; Robinson S; Gray IP; Mather H; Johnston DG Clin Endocrinol (Oxf); 1994 Jan; 40(1):55-62. PubMed ID: 8306481 [TBL] [Abstract][Full Text] [Related]
9. Insulin sensitivity in women at risk of coronary heart disease and the effect of a low glycemic diet. Frost G; Leeds A; Trew G; Margara R; Dornhorst A Metabolism; 1998 Oct; 47(10):1245-51. PubMed ID: 9781629 [TBL] [Abstract][Full Text] [Related]
10. Insulin resistance and coronary artery disease. Bressler P; Bailey SR; Matsuda M; DeFronzo RA Diabetologia; 1996 Nov; 39(11):1345-50. PubMed ID: 8933003 [TBL] [Abstract][Full Text] [Related]
11. Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats. Wilkes JJ; Nelson E; Osborne M; Demarest KT; Olefsky JM Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E617-24. PubMed ID: 15536205 [TBL] [Abstract][Full Text] [Related]
12. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling. Young PW; Cawthorne MA; Coyle PJ; Holder JC; Holman GD; Kozka IJ; Kirkham DM; Lister CA; Smith SA Diabetes; 1995 Sep; 44(9):1087-92. PubMed ID: 7657033 [TBL] [Abstract][Full Text] [Related]
13. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Levin K; Daa Schroeder H; Alford FP; Beck-Nielsen H Diabetologia; 2001 Jul; 44(7):824-33. PubMed ID: 11508266 [TBL] [Abstract][Full Text] [Related]
14. Saturated fatty acid-induced insulin resistance in rat adipocytes. Hunnicutt JW; Hardy RW; Williford J; McDonald JM Diabetes; 1994 Apr; 43(4):540-5. PubMed ID: 8138059 [TBL] [Abstract][Full Text] [Related]
15. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study. Charles MA; Eschwège E; Thibult N; Claude JR; Warnet JM; Rosselin GE; Girard J; Balkau B Diabetologia; 1997 Sep; 40(9):1101-6. PubMed ID: 9300248 [TBL] [Abstract][Full Text] [Related]
16. Metabolic features of patients with and without coronary heart disease but with a superimposable cluster of cardiovascular risk factors. Paolisso G; Gambardella A; Galzerano D; D'Amore A; Balbi V; Varricchio M; D'Onofrio F Coron Artery Dis; 1993 Dec; 4(12):1085-91. PubMed ID: 8162239 [TBL] [Abstract][Full Text] [Related]
17. Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors. Ariza CR; Frati AC; Gómez G; Almazán A Arch Med Res; 1997; 28(1):115-9. PubMed ID: 9078598 [TBL] [Abstract][Full Text] [Related]
19. Central role of the adipocyte in insulin resistance. Bergman RN; Mittelman SD J Basic Clin Physiol Pharmacol; 1998; 9(2-4):205-21. PubMed ID: 10212835 [TBL] [Abstract][Full Text] [Related]
20. Lack of association between central adiposity and lipaemia in UK Sikh men. Lovegrove JA; Brady LM; Lesauvage SV; Lovegrove SS; Minihane AM; Williams CM Int J Obes Relat Metab Disord; 2003 Nov; 27(11):1373-82. PubMed ID: 14574349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]